Literature DB >> 30228708

Prostate Cancer Pathology: Recent Updates and Controversies.

Jennifer K Sehn1.   

Abstract

Prostate cancer is common, and recent efforts in clinical management have focused on identifying patients who could be candidates from less aggressive management or who could benefit from more aggressive therapy. As prostate cancer histology, especially Gleason score, plays a critical role in predicting patient outcomes, attempts have been made to refine histologic classification and reporting in prostate cancer to facilitate patient risk stratification. This review discusses recent updates in prostate cancer grading and reporting.

Entities:  

Mesh:

Year:  2018        PMID: 30228708      PMCID: PMC6139855     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  17 in total

1.  Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.

Authors:  Jesse K McKenney; Wei Wei; Sarah Hawley; Heidi Auman; Lisa F Newcomb; Hilary D Boyer; Ladan Fazli; Jeff Simko; Antonio Hurtado-Coll; Dean A Troyer; Maria S Tretiakova; Funda Vakar-Lopez; Peter R Carroll; Matthew R Cooperberg; Martin E Gleave; Raymond S Lance; Dan W Lin; Peter S Nelson; Ian M Thompson; Lawrence D True; Ziding Feng; James D Brooks
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

2.  Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists.

Authors:  Rajal B Shah; Jianbo Li; Liang Cheng; Lars Egevad; Fang-Ming Deng; Samson W Fine; Lakshmi P Kunju; Jonathan Melamed; Rohit Mehra; Adeboye O Osunkoya; Gladell P Paner; Steve S Shen; Toyonori Tsuzuki; Kiril Trpkov; Wei Tian; Ximing J Yang; Ming Zhou
Journal:  Am J Surg Pathol       Date:  2015-09       Impact factor: 6.394

3.  Reporting intraductal carcinoma of the prostate: a plea for greater standardization.

Authors:  Murali Varma; Lars Egevad; Brett Delahunt; Glen Kristiansen
Journal:  Histopathology       Date:  2016-11-10       Impact factor: 5.087

4.  Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.

Authors:  Francesca Khani; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

5.  Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations.

Authors:  Ming Zhou; Jianbo Li; Liang Cheng; Lars Egevad; Fang-Ming Deng; Lakshmi Priya Kunju; Cristina Magi-Galluzzi; Jonathan Melamed; Rohit Mehra; Savvas Mendrinos; Adeboye O Osunkoya; Gladell Paner; Steve S Shen; Toyonori Tsuzuki; Kiril Trpkov; Wei Tian; Ximing Yang; Rajal B Shah
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

6.  Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

Authors:  Guido Sauter; Till Clauditz; Stefan Steurer; Corinna Wittmer; Franziska Büscheck; Till Krech; Florian Lutz; Maximilian Lennartz; Luisa Harms; Lisa Lawrenz; Christina Möller-Koop; Ronald Simon; Frank Jacobsen; Waldemar Wilczak; Sarah Minner; Maria Christina Tsourlakis; Viktoria Chirico; Sören Weidemann; Alexander Haese; Thomas Steuber; Georg Salomon; Michael Matiu; Eik Vettorazzi; Uwe Michl; Lars Budäus; Derya Tilki; Imke Thederan; Dirk Pehrke; Burkhard Beyer; Christoph Fraune; Cosima Göbel; Marie Heinrich; Manuela Juhnke; Katharina Möller; Ahmed Abdulwahab Abdullah Bawahab; Ria Uhlig; Hartwig Huland; Hans Heinzer; Markus Graefen; Thorsten Schlomm
Journal:  Eur Urol       Date:  2017-01-20       Impact factor: 20.096

7.  Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

Authors:  Brandon A Mahal; Vinayak Muralidhar; Yu-Wei Chen; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Christopher J Sweeney; James B Yu; Felix Y Feng; Quoc-Dien Trinh; Paul L Nguyen
Journal:  BJU Int       Date:  2015-08-22       Impact factor: 5.588

Review 8.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

9.  Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.

Authors:  Bonnie Choy; Shane M Pearce; Blake B Anderson; Arieh L Shalhav; Gregory Zagaja; Scott E Eggener; Gladell P Paner
Journal:  Am J Surg Pathol       Date:  2016-10       Impact factor: 6.394

10.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

Authors:  Jonathan I Epstein; Michael J Zelefsky; Daniel D Sjoberg; Joel B Nelson; Lars Egevad; Cristina Magi-Galluzzi; Andrew J Vickers; Anil V Parwani; Victor E Reuter; Samson W Fine; James A Eastham; Peter Wiklund; Misop Han; Chandana A Reddy; Jay P Ciezki; Tommy Nyberg; Eric A Klein
Journal:  Eur Urol       Date:  2015-07-10       Impact factor: 20.096

View more
  15 in total

Review 1.  The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.

Authors:  Élora Midavaine; Jérôme Côté; Philippe Sarret
Journal:  Cancer Metastasis Rev       Date:  2021-05-11       Impact factor: 9.264

2.  Racial/ethnic disparities in patient experiences with care and Gleason score at diagnosis of prostate cancer: a SEER-CAHPS study.

Authors:  Stephanie Navarro; Xiaohui Hu; Aaron Mejia; Carol Y Ochoa; Trevor A Pickering; Leslie Ballas; Albert J Farias
Journal:  Cancer Causes Control       Date:  2022-01-15       Impact factor: 2.506

3.  Analysis of Prostate Adenocarcinoma Histopathological Types in Relation to Tumor Grade.

Authors:  Andrei PĂnuŞ; Cristiana Eugenia Simionescu; Petru Octavian DrĂgoescu; Paul Tomescu; Alex Emilian Stepan
Journal:  Curr Health Sci J       Date:  2020-12-31

Review 4.  Glycosylation Changes in Prostate Cancer Progression.

Authors:  William Butler; Jiaoti Huang
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

5.  Effects of Psychological Intervention on Perioperative Quality of Life and Serum PSA and FPSA Levels of Patients with Prostate Cancer Treated with Integrated Traditional Chinese and Western Medicine.

Authors:  Xifeng Sun; Yi Lu; Hongxia Zhu; Rui Li; Donghua Zhang; Kunfang Pang
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-26       Impact factor: 2.629

6.  The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues.

Authors:  Chenghuang Shen; Chunliang Tung; Chunnun Chao; Yeongchin Jou; Shupei Huang; Menghsiao Meng; Deching Chang; Peilain Chen
Journal:  BMC Cancer       Date:  2021-10-24       Impact factor: 4.430

7.  Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction.

Authors:  Giulia Dal Santo; Marco Frasca; Gloria Bertoli; Isabella Castiglioni; Claudia Cava
Journal:  Comput Struct Biotechnol J       Date:  2022-02-07       Impact factor: 7.271

8.  miRNA-214-5p inhibits prostate cancer cell proliferation by targeting SOX4.

Authors:  Guangchi Xu; Yin Meng; Lihe Wang; Bo Dong; Feifei Peng; Songtao Liu; Shukui Li; Tao Liu
Journal:  World J Surg Oncol       Date:  2021-12-04       Impact factor: 2.754

9.  PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer.

Authors:  Ioannis Tamposis; Ioannis Tsougos; Anastasios Karatzas; Katerina Vassiou; Marianna Vlychou; Vasileios Tzortzis
Journal:  Appl Clin Inform       Date:  2022-01-19       Impact factor: 2.342

10.  Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database.

Authors:  Laura Boldrini; Pinuccia Faviana; Luca Galli; Federico Paolieri; Paola Anna Erba; Massimo Bardi
Journal:  Genes (Basel)       Date:  2021-08-29       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.